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aBsTracT
inTroDucTion: Progressive supranuclear palsy is a neurodegenerative disorder, described as a tauopa-
thy. The neuroimaging and visual symptoms are among the most important in the diagnosis of this disease. 
The ophthalmoparesis mainly concerns voluntary eye movements. Patients mostly present with vertical pal-
sy, involuntary eye movements, convergence insufficiency, and diplopia.
casE rEPorT: A 62-year-old female patient was admitted to the hospital because of the gait distur-
bance and frequent falls. She had impaired memory, handwriting and speech for one year. On neurological 
and neuro-ophthalmological examinations, the patient presented with vertical gaze palsy, involuntary eye 
movements, dysarthria, tremor in the right hand, and cerebellar ataxia. Blood tests were normal. (18F)-FDG 
PET revealed bilateral zones of moderate hipometabolism in the regions of posterior frontal cortex, anteri-
or cingulum, left thalamus, head of left striatum, and left temporal lobe. Neuropsychological tests revealed 
cognitive impairment (MMSE-26; IADL-1).
conclusion: Based on the literature review and our own notices, we suggest that (18F)-FDG PET scan-
ning and neuro-ophthalmological examination in addition to structural neuroimaging and clinical find-
ings play a crucial role in the differential diagnosis of PSP and other parkinsonian syndromes.
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inTroDucTion
Progressive supranuclear palsy (PSP), known as 
Steele-Richardson-Olszewski syndrome is a neuro-
degenerative disease, described as a tauopathy (4,14). 
The cardinal clinical characteristics include supra-
nuclear dysfunction accompanied by extrapyrami-
dal symptoms (Parkinsonism), cognitive impair-
ment, gait disturbance, and frequent falls (2,5,10). 
The principal cerebral areas of the brain affected are 
the basal ganglia (subthalamic nucleus, substantia 
nigra, and globus pallidus), brainstem (midbrain), 
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frontal cerebral cortex, and the cerebellum (dentate 
nucleus).
According to the literature, the differential di-
agnosis with parkinsonian syndromes is based on 
the neurological, neuro-ophthalmological, and neu-
roimaging findings (1,3,6,8). It is well-known that 
the visual symptoms are among the most impor-
tant in the diagnosis of PSP. The ophthalmoparesis 
mainly concerns voluntary eye movements. Clini-
cal data support the notion that patients may pres-
ent with vertical palsy, involuntary eye movements 
called “square-wave jerks”, convergence insufficien-
cy, and diplopia (double vision) (2,5,15). In addition, 
structural and functional neuroimaging is an impor-
tant marker for the differential diagnosis of PSP, id-
iopathic Parkinson’s disease, and other parkinsonian 
syndromes (7,9,11,13). Respectively, a large group of 
(18-FDG)-PET studies reveal decreased glucose met-
abolic activity in bilateral frontal cortex, striatum, 
and cerebellum (1,3,6,12,15). 
In accordance with previously reported obser-
vations, we describe a case of PSP and try to assess 
the discriminative power of neuro-ophthalmological 
and (18-FDG)-PET findings to differentiate this se-
rious movement disorder from other parkinsonian 
syndromes. 
casE rEPorT
A 62-year-old female patient was admitted 
to the hospital because of the gait disturbance that 
caused imbalance and frequent falls with traumat-
ic injuries. She had impaired memory, handwrit-
ing and speech since one year. On neurological and 
neuro-ophthalmological examination, the patient 
presented with vertical gaze palsy, involuntary eye 
movements („square-wave jerks“), dysarthria, trem-
or in the right hand, and cerebellar ataxia. Standard 
blood tests were normal. MRI showed mild moderate 
brain atrophy. (18F)-FDG PET (Fig.1-2) revealed bi-
lateral zones of moderate hipometabolism in the re-
gions of posterior frontal cortex, anterior cingulum, 
left thalamus, head of left striatum, and left temporal 
lobe (old infarction in the left middle cerebral artery). 
Neuropsychological tests revealed mild cognitive im-
pairment (MMSE-26; IADL-1). 
Discussion
Here, we present the clinical description, typi-
cal neuro-ophthalmological findings, and function-
al neuroimaging of a patient with progressive supra-
nuclear palsy, identified by clinical diagnostic crite-
ria of National Institute of Neurological Disorders 
and Stroke and the Society for PSP (NINDS-SPSP) 
(4). According to the previous reports, the early de-
tection and differential diagnosis of this neurode-
generative disorder is based mainly on specific vi-
sual symptoms accompanied with cognitive decline 
and parkinsonian clinical manifestations (2,5,9,13). 
In our case, the neuro-ophthalmological examina-
tion found vertical (up- and downward) gaze pal-
sy and horizontal saccades (involuntary eye move-
ments mimicking nistagmus). Recent studies reveal 
that certain visual symptoms accompanied with fre-
quent falls are clinical hallmarks of the major PSP 
subgroup, defined as Richardson’s syndrome (RS) 
(1,6,8). Respectively, our neuro-ophthalmological 
findings are in contrast to the subgroup of patients 
who refer to PSP-parkinsonism (PSP-P), presenting 
primarily with asymmetric extrapyramidal symp-
toms (bradykinesia, rigidity, and tremor) and mod-
est responsiveness to levodopa therapy.
Although the anatomical neuroimaging is use-
ful in PSP diagnosis, it is generally limited to the ex-
clusion of cerebrovascular infarction, brain tumor, 
lobar atrophy or other structural pathology that 
causes similar clinical manifestations (4,10). Usual-
ly magnetic resonance imaging (MRI) shows atro-
phy of upper brain stem, superior cerebellar pedun-
cles, and dilation of third ventricle. In accordance, we 
found moderate brain atrophy on our MRI scans.
Several works confirm the clinical usefulness 
of nuclear medicine techniques in PSP diagnosis and 
discrimination from other parkinsonian syndromes 
(7,11,14). Respectively, (18-F)-FDG PET allows the 
characterization of cerebral hipometabolism in PSP 
patients (3,6,9,12,15). In relation, our radiological 
findings detected similar decrease in glucose meta-
bolic activity in bilateral posterior frontal cortex, an-
terior cingulum, left thalamus, head of left striatum, 
and left temporal lobe. These notices corresponded 
to major clinical features (frequent falls, mild cog-
nitive impairment, and tremor) and neuro-ophthal-
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mological abnormalities (vertical gaze palsy and hor-
izontal saccades) described in our case report. 
Despite the recent advances in understanding 
of PSP pathophysiology, imaging techniques, and ge-
netic analyses, the diagnostic accuracy of this neuro-
degenerative disorder remains difficult. Accordingly, 
we suggest that the combining of clinical, neuro-op-
thalmological, and radiological markers shows great 
potential for improvement of PSP diagnosis and its 
determination from other movement disorders.   
conclusion
Based on the literature review and our own 
notices, we suggest that (18F)-FDG PET scanning and 
neuro-ophthalmological examination in addition to 
structural neuroimaging and clinical findings may 
play a crucial role in the early recognition of patients 
with PSP and differential diagnosis with various 
parkinsonian syndromes.
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Fig. 1-2. (18F)-FDG PET reveals bilateral zones of mod-
erate hipometabolism in the regions of posterior frontal 
cortex, anterior cingulum, head of left striatum, and left 
temporal lobe
